Uracil

thymidylate synthetase ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30927565 Design, synthesis and biological evaluation of novel uracil derivatives bearing 1, 2, 3-triazole moiety as thymidylate synthase (TS) inhibitors and as potential antitumor drugs. 2019 Jun 1 4
2 28796306 Enzyme Activation with a Synthetic Catalytic Co-enzyme Intermediate: Nucleotide Methylation by Flavoenzymes. 2017 Oct 2 1
3 27517750 Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage. 2016 Sep 13 1
4 25997777 Thymidylate synthase inspired biomodel reagent for the conversion of uracil to thymine. 2015 Jun 21 1
5 26271935 Correction: Thymidylate synthase inspired biomodel reagent for the conversion of uracil to thymine. 2015 Sep 18 2
6 23253900 SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress. 2013 Mar-Apr 1
7 20647221 Associations of various gene polymorphisms with toxicity in colorectal cancer patients receiving oral uracil and tegafur plus leucovorin: a prospective study. 2011 Feb 1
8 21222484 Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA. 2011 Feb 8 1
9 20044377 Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biology. 2010 Jan 1 1
10 19370033 An unusual mechanism of thymidylate biosynthesis in organisms containing the thyX gene. 2009 Apr 16 1
11 17143493 Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase. 2007 Jan 1
12 17659576 Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. 2007 Sep 1
13 15785747 Clinical application of biological markers for treatments of resectable non-small-cell lung cancers. 2005 Apr 11 1
14 15322254 Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition. 2004 Sep 1
15 14636615 Predictive value of immunohistochemical thymidylate synthase expression for histological response to Tegafur/Uracil (UFT) in oral squamous cell carcinoma. 2003 Dec 1
16 11487279 The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. 2001 Aug 3 1
17 12450432 Thymidylate synthase pharmacogenetics in colorectal cancer. 2001 Nov 2
18 10952785 Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331. 2000 Sep 2
19 8206932 Effect of 5-fluoro- and 5-bromouracil substitution on the translation of human thymidylate synthase mRNA. 1994 Jun 10 6
20 8464418 [Changes of the number of FdUMP binding sites of thymidylate synthase and folate pools in human colorectal carcinomas following the administration of tegafur and uracil: preliminary report]. 1993 Feb 1
21 1910444 Linear free energy-related and quantitative structure-activity relationships of inhibitors of thymidylate synthetase. 1991 1
22 2015598 Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. 1991 May 1 1
23 2495166 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase. 1989 May 1 2